| Crystal Bocardo-palomino, LVN | |
|
15229 Amar Rd, La Puente, CA 91744-2066 | |
| (626) 855-5090 | |
| Not Available |
| Full Name | Crystal Bocardo-palomino |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 15229 Amar Rd, La Puente, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427420413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | VN 279163 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Crystal Bocardo-palomino, LVN 14345 Flynn St, La Puente, CA 91744-2431 Ph: (626) 664-1305 | Crystal Bocardo-palomino, LVN 15229 Amar Rd, La Puente, CA 91744-2066 Ph: (626) 855-5090 |
News Archive
A new study at the Montreal Neurological Institute at McGill University identifies a key mechanism for the normal development of motor nerve cells (motor neurons) - cells that control muscles. This finding is crucial to understanding and treating a range of conditions involving nerve cell loss or damage, from spinal cord injury to neurodegenerative diseases such as ALS, also known as Lou Gehrig's disease.
The House Ways and Means Subcommittee on Health will examine oversight of the Medicare prescription drug benefit among other priorities for the 110th Congress, House Ways and Means Committee Chair Charles Rangel (D-N.Y.) and ranking member Jim McCrery (R-La.) wrote in a letter sent last Wednesday to leaders of the House Oversight and Government Reform Committee and the House Administration Committee, CQ HealthBeat reports.
About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both.
Array BioPharma Inc. has announced the presentation of preclinical data on a novel small molecule glucokinase activator (GKA), ARRY-403, a drug for the treatment of Type 2 diabetes.
A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.
› Verified 1 days ago